166 related articles for article (PubMed ID: 27775850)
21. Exploring
Mansoor A; Akhter A; Hamidi M; Roshan TM; Shabani-Rad MT; Stewart D
Anticancer Res; 2023 Nov; 43(11):4801-4807. PubMed ID: 37909960
[TBL] [Abstract][Full Text] [Related]
22. [Investigation for pathological interpretation criteria and its prognostic value for P53 expression in Chinese diffuse large B-cell lymphoma].
Shi YF; Gao ZF; Li XH; Guo LG; Zheng QL; Long MP; Deng LJ; Du TT; Jia L; Zhao W; Song XX; Li M
Zhonghua Xue Ye Xue Za Zhi; 2022 Dec; 43(12):1010-1015. PubMed ID: 36709106
[No Abstract] [Full Text] [Related]
23. Analysis and Investigation of Bioinformatics and Epigenetics Reveal the Underlying Mechanisms by which FLOT2 Modulates the Progression of Diffuse Large B-cell Lymphoma.
Zhang Y; Chen Y; Guo Q; Zhang Y; Liu A
Discov Med; 2024 Mar; 36(182):621-631. PubMed ID: 38531803
[TBL] [Abstract][Full Text] [Related]
24. Distinct peripheral T-cell and NK-cell profiles in HGBL-MYC/BCL2 vs patients with DLBCL NOS.
de Jonge AV; Duetz C; Bruins WSC; Korst CLBM; Rentenaar R; Cosovic M; Eken M; Twickler I; Nijland M; van der Poel MWM; de Heer K; Klerk CPW; Strobbe L; Oosterveld M; Boersma R; Koene HR; Roemer MGM; van Werkhoven E; Chamuleau MED; Mutis T
Blood Adv; 2024 Mar; 8(5):1094-1104. PubMed ID: 38191686
[TBL] [Abstract][Full Text] [Related]
25. Tumoural Pellino-1 expression and Pellino-1-expressive cytotoxic T-cells are associated with poor prognosis in diffuse large B-cell lymphoma.
Shin SJ; Ko J; Hwang HS; Huh J; Lee CW; Lee JK; Go H
Pathology; 2024 Apr; 56(3):374-381. PubMed ID: 38296676
[TBL] [Abstract][Full Text] [Related]
26. The biology and treatment of Epstein-Barr virus-positive diffuse large B cell lymphoma, NOS.
Li JW; Deng C; Zhou XY; Deng R
Heliyon; 2024 Jan; 10(1):e23921. PubMed ID: 38234917
[TBL] [Abstract][Full Text] [Related]
27. Insertion of atypical glycans into the tumor antigen-binding site identifies DLBCLs with distinct origin and behavior.
Chiodin G; Allen JD; Bryant DJ; Rock P; Martino EA; Valle-Argos B; Duriez PJ; Watanabe Y; Henderson I; Blachly JS; McCann KJ; Strefford JC; Packham G; Geijtenbeek TBH; Figdor CG; Wright GW; Staudt LM; Burack R; Bowden TA; Crispin M; Stevenson FK; Forconi F
Blood; 2021 Oct; 138(17):1570-1582. PubMed ID: 34424958
[TBL] [Abstract][Full Text] [Related]
28. Unraveling the enigma of B cells in diffuse large B-cell lymphoma: unveiling cancer stem cell-like B cell subpopulation at single-cell resolution.
Liu F; Zheng J; Yang G; Pan L; Xie Y; Chen S; Tuo J; Su J; Ou X; Liu R
Front Immunol; 2023; 14():1310292. PubMed ID: 38149239
[TBL] [Abstract][Full Text] [Related]
29. Molecular characterization and genetic subclassification comparison of diffuse large B-cell lymphoma (DLBCL) - real-life experience with 74 cases.
Ivanova VS; Vela V; Dirnhofer S; Dobbie M; Stenner F; Knoblich J; Tzankov A; Menter T
Pathobiology; 2023 Dec; ():. PubMed ID: 38128501
[TBL] [Abstract][Full Text] [Related]
30. Diffuse Large B-Cell Lymphoma, Not Otherwise Specified (DLBCL NOS) Presenting as Multiple Subcutaneous Nodules: An Unusual Cutaneous Presentation of Systemic Disease.
Tavberidze N; Bennett DD; Matson DR
Case Rep Pathol; 2023; 2023():2960965. PubMed ID: 37822715
[TBL] [Abstract][Full Text] [Related]
31. Comprehensive characterization of driver genes in diffuse large B cell lymphoma.
Fan Z; Pei R; Sha K; Chen L; Wang T; Lu Y
Oncol Lett; 2020 Jul; 20(1):382-390. PubMed ID: 32565964
[TBL] [Abstract][Full Text] [Related]
32. ETS1 phosphorylation at threonine 38 is associated with the cell of origin of diffuse large B cell lymphoma and sustains the growth of tumour cells.
Chung EYL; Sartori G; Ponzoni M; Cascione L; Priebe V; Xu-Monette ZY; Fang X; Zhang M; Visco C; Tzankov A; Rinaldi A; Sgrignani J; Zucca E; Rossi D; Cavalli A; Inghirami G; Scott DW; Young KH; Bertoni F
Br J Haematol; 2023 Oct; 203(2):244-254. PubMed ID: 37584198
[TBL] [Abstract][Full Text] [Related]
33. Co-expression of regulatory B-cell markers, transforming growth factor β and interleukin-10 as a prognostic factor in diffuse large B-cell lymphoma.
Mishina T; Miyoshi H; Takeuchi M; Miyawaki K; Nakashima K; Yamada K; Moritsubo M; Inoue-Mitsuyama K; Shimasaki Y; Imamoto T; Kawamoto K; Furuta T; Kohno K; Kato K; Akashi K; Ohshima K
Pathol Res Pract; 2024 Feb; 254():155117. PubMed ID: 38262270
[TBL] [Abstract][Full Text] [Related]
34. Comprehensive analysis of HDAC7 expression and its prognostic value in diffuse large B cell lymphoma: A review.
Lu W; Zhuang G; Guan Y; Li Y; Liu L; Xiao M
Medicine (Baltimore); 2023 Nov; 102(45):e34577. PubMed ID: 37960766
[TBL] [Abstract][Full Text] [Related]
35. Integrative analyses reveal outcome-associated and targetable molecular partnerships between TP53, BRD4, TNFRSF10B, and CDKN1A in diffuse large B-cell lymphoma.
Forberg AL; Unrau J; Weber KS; Rutz AC; Lund S; Guidinger J; Pelzel A; Hauge J; Hemmen AJ; Hartert KT
Ann Hematol; 2024 Jan; 103(1):199-209. PubMed ID: 37792064
[TBL] [Abstract][Full Text] [Related]
36. Clinical boundaries in adult cases of large B cell lymphoma with IRF4 rearrangement.
Maguire J; Harvey H; Jones A; Law R; Bashir M; O'Brien O; Sargent J; Grant C; Flavin R
Histopathology; 2024 Jan; 84(2):399-401. PubMed ID: 37876327
[TBL] [Abstract][Full Text] [Related]
37. Integrative analysis reveals an outcome-associated and targetable pattern of p53 and cell cycle deregulation in diffuse large B cell lymphoma.
Monti S; Chapuy B; Takeyama K; Rodig SJ; Hao Y; Yeda KT; Inguilizian H; Mermel C; Currie T; Dogan A; Kutok JL; Beroukhim R; Neuberg D; Habermann TM; Getz G; Kung AL; Golub TR; Shipp MA
Cancer Cell; 2012 Sep; 22(3):359-72. PubMed ID: 22975378
[TBL] [Abstract][Full Text] [Related]
38. Gene Mutation Profiles in Primary Diffuse Large B Cell Lymphoma of Central Nervous System: Next Generation Sequencing Analyses.
Todorovic Balint M; Jelicic J; Mihaljevic B; Kostic J; Stanic B; Balint B; Pejanovic N; Lucic B; Tosic N; Marjanovic I; Stojiljkovic M; Karan-Djurasevic T; Perisic O; Rakocevic G; Popovic M; Raicevic S; Bila J; Antic D; Andjelic B; Pavlovic S
Int J Mol Sci; 2016 May; 17(5):. PubMed ID: 27164089
[TBL] [Abstract][Full Text] [Related]
39. Different spatial distribution of inflammatory cells in the tumor microenvironment of ABC and GBC subgroups of diffuse large B cell lymphoma.
Guidolin D; Tamma R; Annese T; Tortorella C; Ingravallo G; Gaudio F; Perrone T; Musto P; Specchia G; Ribatti D
Clin Exp Med; 2021 Nov; 21(4):573-578. PubMed ID: 33959827
[TBL] [Abstract][Full Text] [Related]
40. Identification of the shared gene signatures and molecular pathways in systemic lupus erythematosus and diffuse large B-cell lymphoma.
Li H; Zhou J; Zhou L; Zhang X; Shang J; Feng X; Yu L; Fan J; Ren J; Zhang R; Duan X
J Gene Med; 2023 Dec; 25(12):e3558. PubMed ID: 37392050
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
